KEAP1 and neoplasm: Likewise, an elegant study utilizing a KrasG12D/+; p53−/−;KEAP1R470C with a Y chromosome-driven model antigen introduced into female immunocompetent hosts revealed enhanced tumor growth relative to KEAP1-wildtype tumors [60].